Est. 2015 · United Kingdom · USA · Austria
Lung-Cancer-26
2nd AnnualInvitation Only

Lung Cancer

USFocus Meeting 2027
Two days, 48 people, one room.
April 30 to May 1, 2027
NOPSI Hotel, New Orleans, LA
Support Opportunities →
Dates
April 30-May 1, 2027
Two-day program
Venue
NOPSI Hotel
New Orleans, LA
Audience
48 by invitation
24 KOLs & 24 fellows
Format
8 sessions · 24 talks
Expert talks + moderated panels

A Curated Room: The People Shaping Practice

Now in its second year, this invitation-only meeting convenes a deliberately small faculty: 24 leading thoracic oncology KOLs alongside 24 hand-selected fellows and junior faculty, the clinicians defining today’s standards and the ones who will define the next decade’s, in one room for two days.

The science tracks where treatment is moving: immunotherapy in advanced and early-stage disease, oncogene-driven NSCLC from EGFR to fusions and rare mutations, small cell, and rare thoracic tumors. Every session pairs three expert talks with a moderated panel, sustained, close-quarters engagement rather than a lecture hall.

Advanced NSCLC ImmunotherapyEGFR, Fusions & Rare MutationsSmall Cell Lung CancerPerioperative & ConsolidationMRD & Liquid BiopsyMesothelioma · Thymic · MTAP
Meeting Co-Chairs
Listed alphabetically by surname
Charu Aggarwal
Charu Aggarwal
University of Pennsylvania, Philadelphia, PA
Stephen Liu
Stephen Liu
Georgetown Lombardi Comprehensive Cancer Center, Washington, DC
Faculty Drawn From
MD Anderson · Memorial Sloan Kettering · Dana-Farber · Johns Hopkins · Massachusetts General and other leading US cancer centers
48
Invited attendees only, sustained access, not a crowd
1:1
KOLs to rising faculty, a hand-picked balance in every session
21
Established meetings across the US and Europe, a proven platform
Lung Cancer US Focus Meeting 2027

Confirmed Faculty

Listed alphabetically by surname
Charu Aggarwal
University of Pennsylvania, Philadelphia, PA
Laura Alder
Duke Cancer Institute, Durham, NC
Mariam Alexander
Medical University of South Carolina, Charleston, SC
Lyudmila Bazhenova
University of California San Diego Health, La Jolla, CA
Christine Bestvina
The University of Chicago Medicine, Chicago, IL
Hossein Borghaei
Fox Chase Cancer Center, Philadelphia, PA
Jamie Chaft
Memorial Sloan Kettering Cancer Center, New York, NY
Alexander Drilon
Memorial Sloan Kettering Cancer Center, New York, NY
Narjust Florez
Dana-Farber Cancer Institute, Boston, MA
Justin Gainor
Massachusetts General Hospital, Boston, MA
Ryan Gentzler
University of Virginia School of Medicine, Charlottesville, VA
Balazs Halmos
Albert Einstein College of Medicine, Bronx, NY
Brian Henick
Columbia University Irving Medical Center, New York, NY
Chul Kim
Georgetown Lombardi Comprehensive Cancer Center, Washington, DC
Ticiana Leal
Winship Cancer Institute of Emory University, Atlanta, GA
Jessica Lin
Massachusetts General Hospital, Boston, MA
Stephen Liu
Georgetown Lombardi Comprehensive Cancer Center, Washington, DC
Christine Lovly
City of Hope, Duarte, CA
Melina Marmarelis
University of Pennsylvania, Philadelphia, PA
Zofia Piotrowska
Massachusetts General Hospital, Boston, MA
Jonathan Riess
University of California Davis Health, Sacramento, CA
Christian Rolfo
The Ohio State University Comprehensive Cancer Center, Columbus, OH
Ferdinandos Skoulidis
The University of Texas MD Anderson Cancer Center, Houston, TX
Liza Villaruz
University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA
Helena Yu
Memorial Sloan Kettering Cancer Center, New York, NY
Further faculty to be announced
Two Days, Eight Sessions

Proposed Agenda

Presentations15 min
Panel Discussions30 min
Coffee Breaks20 min
Lunch Breaks65 min
Day One · Friday, April 30, 2027
Session IImmunotherapy for Advanced NSCLC
ModeratorTBC
PD(L)1-Based Standards
Liza VillaruzUniversity of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA
ADC + IO and other Combinations
Jonathan RiessUniversity of California Davis Health, Sacramento, CA
Bispecific Antibodies
Hossein BorghaeiFox Chase Cancer Center, Philadelphia, PA
Panel Discussion
Coffee Break
Session IIAdvanced EGFR+
ModeratorTBC
First Line
Zofia PiotrowskaMassachusetts General Hospital, Boston, MA
Second Line+
Christine LovlyCity of Hope, Duarte, CA
Transformed EGFR
Helena YuMemorial Sloan Kettering Cancer Center, New York, NY
Panel Discussion
Lunch Break + Faculty and Fellow Photo
Session IIIAdvanced Fusion+
ModeratorTBC
ALK
Jessica LinMassachusetts General Hospital, Boston, MA
ROS1 and NTRK
Alexander DrilonMemorial Sloan Kettering Cancer Center, New York, NY
RET, NTRK, NRG1
Lyudmila BazhenovaUniversity of California San Diego Health, La Jolla, CA
Panel Discussion
Coffee Break
Session IVAdvanced Mutation+
ModeratorTBC
HER2
Christine BestvinaThe University of Chicago Medicine, Chicago, IL
BRAF and MET
Ryan GentzlerUniversity of Virginia School of Medicine, Charlottesville, VA
KRAS
Ferdinandos SkoulidisThe University of Texas MD Anderson Cancer Center, Houston, TX
Panel Discussion
Partnership Opportunities Now Open

Bespoke engagement packages for a closed, invitation-only audience

Request the Prospectus →
Simon Mayr
Your Point of Contact
Simon Mayr
Chief Operating Officer, MD Education